Patents by Inventor Hideyuki Kishida

Hideyuki Kishida has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Reduced coenzyme Q10 crystal with excellent stability and composition containing said reduced coenzyme Q10 crystal
    Publication number: 20050074860
    Abstract: The present invention provides a reduced coenzyme Q10 crystal with excellent stability and a composition containing said reduced coenzyme Q10 crystals. According to the present invention, after dissolving reduced coenzyme Q10 in a fat and oil, it is cooled, making it possible to obtain reduced coenzyme Q10 crystals with excellent stability and which exhibit an x-ray diffraction pattern (using a CuK? emission line) that differs from ordinary reduced coenzyme Q10 crystals. Moreover, said crystals are also excellent in bioabsorbability.
    Type: Application
    Filed: September 9, 2004
    Publication date: April 7, 2005
    Inventors: Takahiro Ueda, Shiro Kitamura, Taizo Kawabe, Hideyuki Kishida, Yasuyoshi Ueda
  • Ligand for peroxisome proliferator-activated receptor
    Publication number: 20040253329
    Abstract: The object of the present invention is to provide PPAR&ggr; ligand derived from naturally occurring sources and a composition for preventing and/or improving Insulin Resistance Syndrome, diabetes mellitus, obesity or visceral fat obesity comprising the PPAR&ggr; ligand as an active agent.
    Type: Application
    Filed: January 8, 2004
    Publication date: December 16, 2004
    Inventors: Tatsumasa Mae, Misuzu Tsukagawa, Hideyuki Kishida, Mitsuaki Kitano, Mikio Kitahara, Kaku Nakagawa, Minpei Kuroda, Yoshihiro Mimaki, Yutaka Sashida
  • Compositions for preventing or ameliorating multiple risk factor syndromes
    Publication number: 20040028751
    Abstract: The invention aims at a composition for preventing or ameliorating multiple risk factor syndrome involving visceral fat-type obesity, diabetes mellitus, hyperlipemia and hypertension,
    Type: Application
    Filed: September 11, 2003
    Publication date: February 12, 2004
    Inventors: Tatsumasa Mae, Misuzu Tsukagawa, Hideyuki Kishida, Mitsuaki Kitano, Mikio Kitahara, Kaku Nakagawa
  • Ligand for peroxisome proliferator-activated receptor
    Publication number: 20030147979
    Abstract: The object of the present invention is to provide PPAR&ggr; ligand derived from naturally occurring sources and a composition for preventing and/or improving Insulin Resistance Syndrome, diabetes mellitus, obesity or visceral fat obesity comprising the PPAR&ggr; ligand as an active agent.
    Type: Application
    Filed: October 23, 2002
    Publication date: August 7, 2003
    Inventors: Tatsumasa Mae, Misuzu Tsukagawa, Hideyuki Kishida, Mitsuaki Kitano, Mikio Kitahara, Kaku Nakagawa, Minpei Kuroda, Yoshihiro Mimaki, Yutaka Sashida
  • Cognition enhancing quinuclidine compound
    Patent number: 5494917
    Abstract: A cognition enhancer comprising, as an effective ingredient, a bicyclic compound containing nitrogen atom having the general formula (I): ##STR1## or a physiologically acceptable salt thereof.
    Type: Grant
    Filed: October 12, 1994
    Date of Patent: February 27, 1996
    Assignee: Kanegafuchi Kagaku Kogyo Kabushiki Kaisha
    Inventors: Yoshihide Fuse, Kozo Yamamoto, Hideyuki Kishida, Toshiaki Miwa, Takayoshi Hidaka, Ikuo Katsumi
  • Phenoxybenzene derivative
    Patent number: 5270339
    Abstract: There are described a phenoxybenzene derivative having the formula (I): ##STR1## wherein R.sup.1 is hydrogen atom; an alkyl group having 1 to 3 carbon atoms; --OR.sup.6 or a halogen atom,R.sup.2 is hydrogen atom, nitro group or amino group,R.sup.3 is hydrogen atom, an alkyl group having 1 to 8 carbon atoms, a cycloalkyl group having 3 to 5 carbon atoms, allyl group, vinyl group or --(CH.sub.2)n.sup.1 R.sup.7R.sup.4 is hydrogen atom, an alkyl group having 1 to 3 carbon atoms or --(CH.sub.2)n.sup.3 R.sup.25R.sup.5 hydrogen atom; an alkyl group having 1 to 3 carbon atoms; or phenyl group,X is ##STR2## wherein Y is oxygen atom or sulfur atom; or --CHR.sup.27 -- and line means a single bond or a double bond provided that n is 2 in case that the line means a single bond and n is 1 in case that the line means a double bond, ora pharmacologically acceptable salt thereof,a cognition enhancer comprising the same as an effective ingredient andan antidepressant comprising the same as an effective ingredient.
    Type: Grant
    Filed: December 3, 1992
    Date of Patent: December 14, 1993
    Assignee: Kanagafuchi Kagaku Kogyo Kabushiki Kaisha
    Inventors: Kozo Yamamoto, Yoshihide Fuse, Hideyuki Kishida, Naoko Yasuhara, Toshiaki Miwa, Ikuo Katsumi, Takayoshi Hidaka